BR112022025216A2 - Administração de sulcardina para tratamento de fibrilação atrial aguda - Google Patents

Administração de sulcardina para tratamento de fibrilação atrial aguda

Info

Publication number
BR112022025216A2
BR112022025216A2 BR112022025216A BR112022025216A BR112022025216A2 BR 112022025216 A2 BR112022025216 A2 BR 112022025216A2 BR 112022025216 A BR112022025216 A BR 112022025216A BR 112022025216 A BR112022025216 A BR 112022025216A BR 112022025216 A2 BR112022025216 A2 BR 112022025216A2
Authority
BR
Brazil
Prior art keywords
sulcardine
administration
treatment
atrial fibrillation
acute atrial
Prior art date
Application number
BR112022025216A
Other languages
English (en)
Portuguese (pt)
Inventor
Elliott Gary
Gillings Mireille
Goodenow Robert
Mason Jay
Radziszewski Waldemar
Romano Suzanne
Original Assignee
Huyabio Int Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huyabio Int Llc filed Critical Huyabio Int Llc
Publication of BR112022025216A2 publication Critical patent/BR112022025216A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR112022025216A 2020-06-12 2021-06-11 Administração de sulcardina para tratamento de fibrilação atrial aguda BR112022025216A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063038664P 2020-06-12 2020-06-12
PCT/US2021/037098 WO2021252959A1 (en) 2020-06-12 2021-06-11 Sulcardine administration for treatment of acute atrial fibrillation

Publications (1)

Publication Number Publication Date
BR112022025216A2 true BR112022025216A2 (pt) 2023-04-04

Family

ID=78824214

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022025216A BR112022025216A2 (pt) 2020-06-12 2021-06-11 Administração de sulcardina para tratamento de fibrilação atrial aguda

Country Status (14)

Country Link
US (2) US11813245B2 (cg-RX-API-DMAC10.html)
EP (1) EP4164633A4 (cg-RX-API-DMAC10.html)
JP (1) JP2023529196A (cg-RX-API-DMAC10.html)
KR (1) KR20230024347A (cg-RX-API-DMAC10.html)
CN (1) CN116723836A (cg-RX-API-DMAC10.html)
AU (1) AU2021288056A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022025216A2 (cg-RX-API-DMAC10.html)
CA (1) CA3182015A1 (cg-RX-API-DMAC10.html)
CL (1) CL2022003501A1 (cg-RX-API-DMAC10.html)
CO (1) CO2023000194A2 (cg-RX-API-DMAC10.html)
IL (1) IL298907A (cg-RX-API-DMAC10.html)
MX (1) MX2022015834A (cg-RX-API-DMAC10.html)
PH (1) PH12022553396A1 (cg-RX-API-DMAC10.html)
WO (1) WO2021252959A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11813245B2 (en) * 2020-06-12 2023-11-14 Huyabio International, Llc Sulcardine administration for treatment of acute atrial fibrillation
WO2026036095A1 (en) * 2024-08-08 2026-02-12 Huyabio International, Llc J-Tp PROTECTION

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1172908C (zh) * 1999-12-10 2004-10-27 中国科学院上海药物研究所 N-取代苄基或苯基芳香磺酰胺化合物及其用途
CN1939298A (zh) 2005-09-29 2007-04-04 中国科学院上海药物研究所 硫酸舒欣啶固体和靶向制剂及其制备方法
US8541464B2 (en) * 2009-11-17 2013-09-24 HUYA Biosciences International LLC Treatment of atrial fibrillation
WO2011062903A2 (en) * 2009-11-17 2011-05-26 Elliott Gary T Slow infusion of sulcardine and its salts
EP3302442B1 (en) 2015-06-03 2024-10-16 Triastek, Inc. Dosage forms and use thereof
AU2017261372B2 (en) 2016-05-05 2019-02-14 Triastek, Inc. Controlled release dosage form
AU2018212273B2 (en) 2017-01-26 2023-12-21 Triastek, Inc. Dosage forms of controlled release at specific gastrointestinal sites
WO2020123824A1 (en) * 2018-12-13 2020-06-18 Huya Bioscience International, Llc Sulcardine administration for treatment of acute atrial fibrillation
KR102405199B1 (ko) * 2019-01-29 2022-06-02 후야 바이오사이언스 인터내셔널 엘엘씨 설카딘 염
US11813245B2 (en) * 2020-06-12 2023-11-14 Huyabio International, Llc Sulcardine administration for treatment of acute atrial fibrillation

Also Published As

Publication number Publication date
US11813245B2 (en) 2023-11-14
US20240058304A1 (en) 2024-02-22
PH12022553396A1 (en) 2024-04-22
IL298907A (en) 2023-02-01
EP4164633A4 (en) 2024-07-31
WO2021252959A1 (en) 2021-12-16
JP2023529196A (ja) 2023-07-07
CL2022003501A1 (es) 2023-06-09
KR20230024347A (ko) 2023-02-20
EP4164633A1 (en) 2023-04-19
US12465587B2 (en) 2025-11-11
CN116723836A (zh) 2023-09-08
US20210386708A1 (en) 2021-12-16
AU2021288056A1 (en) 2023-02-09
CO2023000194A2 (es) 2023-03-27
CA3182015A1 (en) 2021-12-16
MX2022015834A (es) 2023-04-04

Similar Documents

Publication Publication Date Title
MX2024004332A (es) Metodos de uso de inhibidores de ehmt2 para tratar o prevenir transtornos sanguíneos.
WO2022221528A3 (en) Kras g12c inhibitors
BR112016009209A8 (pt) Método e aparelho para determinar uma matriz de decodificação para decodificar um sinal de áudio codificado, e meio de armazenamento legível por computador
BR112015019049A2 (pt) sinalização de informação de criação de áudio em uma sequência de bits
MX2025004371A (es) Formas en estado solido de (s)-2-(((s)-6,8-difluor-1,2,3,4- tetrahidronaftalen-2-il)amino)-n-(1-(2-metil-1-(neopentilamino)propan-2- il)-1h-imidazol-4-il)pentanamida y usos de la misma
EP4285906A3 (en) Amine-substituted heterocyclic compounds as ehmt2 inhibitors and methods of use thereof
AR119158A1 (es) Tratamientos de angioedema hereditario
MX2020005843A (es) Descodificacion de secuencias de bits de audio con metadatos de replicacion de banda espectral mejorada en al menos un elemento de relleno.
BR112015019435A2 (pt) codificador e decodificador de áudio com informações de programa ou metadados de estrutura de substream
BR112016028586A8 (pt) meio de armazenamento de computador e método implementado por computador para análise de importância de vídeo baseado em regras
BR112022005474A2 (pt) Suavização de metadados de áudio
BR112017026743A2 (pt) aparelho e método de decodificação, programa, e, aparelho e método de codificação
MX2021009806A (es) Ésteres de ácidos grasos de cadena media de beta-hidroxibutirato y butanodiol y composiciones y métodos para usar los mismos.
BR112015007455A2 (pt) método executável por dispositivo cliente para executar fluxo de mídia adaptativo tendo pluralidade de faixas de áudio e dispositivo de mídia player
CR20210373A (es) Tratamiento agudo y tratamiento rápido de la cefalea usando anticuerpos anti-cgrp
RU2017118833A (ru) Способы воздействия на транскрипционный контроль в суперэнхансерных областях
EP4524951A4 (en) SONG GENERATION METHOD, APPARATUS AND SYSTEM, AND STORAGE MEDIA
BR112018007547A2 (pt) adaptação relacionada à tela de conteúdo ambisonic de alta ordem (hoa)
CO2022002731A2 (es) Formas en estado sólido de (s)-2-(((s)-6,8-diflúor-1,2,3,4-tetrahidronaftalen-2-il)amino)-n-(1-(2-metil-1-(neopentilamino)propan-2-il)-1h-imidazol-4-il)pentanamida y usos de la misma
AU2017268795A1 (en) Methods of treating behavioral syndromes using pipradrol
BR112014029458A2 (pt) método e aparelho para avaliação de qualidade de mídia
EP4478185A4 (en) FIRMWARE INTERACTION METHOD AND APPARATUS, AND SERVER AND STORAGE MEDIUM
EP4322545B1 (en) METHOD AND APPARATUS FOR DETERMINING A CLOCK, AND STORAGE SUPPORT
EP4460022A4 (en) Video generation method and apparatus, and device and storage medium
BR112022005736A2 (pt) Compostos de azaindol carboxamida para o tratamento de infecções micobacterianas